Matches in SemOpenAlex for { <https://semopenalex.org/work/W3190198676> ?p ?o ?g. }
- W3190198676 endingPage "e2119600" @default.
- W3190198676 startingPage "e2119600" @default.
- W3190198676 abstract "<h3>Importance</h3> In the literature on opioid use disorder (OUD), opioid abstinence is used as an outcome measure for individuals receiving medication-assisted treatment (MAT), without consideration of patient-reported goals (PRGs). <h3>Objectives</h3> To identify common PRGs for youths receiving MAT for OUD and assess whether these patients achieve their stated goals. <h3>Design, Setting, and Participants</h3> This prospective cohort study examined data from 152 individuals aged 16 to 25 years (noninclusive) recruited between May 22, 2018, and March 11, 2020, from 45 outpatient MAT clinics in the Pharmacogenetics of Opioid Substitution Treatment Response study. Youths receiving MAT for OUD were included and were followed up for 3 months. <h3>Exposures</h3> Medication-assisted treatment for OUD. <h3>Main Outcomes and Measures</h3> The frequency of each PRG; the success of goal attainment, compared between those who reported specific PRGs and those who did not; and associations between reporting certain goals and achieving them. <h3>Results</h3> Among the 152 youths in the study, 82 were male (53.9%), and the mean (SD) age was 22.8 (1.8) years. Ten overarching goals were identified, with the most common being to taper the dose of or stop MAT (96 [63.2%]), avoid use of recreational substances (71 [46.7%]), manage OUD symptoms (25 [16.4%]), live a normal life (14 [9.2%]), improve mental health (11 [7.2%]), and gain employment (8 [5.3%]). Overall, individuals who reported PRGs had similar odds of achieving them as those who did not for the goals of taper dose of or stop MAT (OR, 1.98; 95% CI, 0.88-4.46;<i>P</i> = .10), avoid recreational substances (OR, 1.34; 95% CI, 0.65-2.74;<i>P</i> = .43), manage OUD symptoms (β coefficient, –0.93; 95% CI, –4.24 to 2.38;<i>P</i> = .58), and improve mental health (β coefficient, –0.76; 95% CI, –6.31 to 4.78;<i>P</i> = .79). Furthermore, multivariable logistic regression showed that goals to taper the dose of or stop MAT (odds ratio, 1.90; 95% CI, 0.78-4.63;<i>P</i> = .16) or avoid recreational substances (odds ratio, 1.27; 95% CI, 0.60-2.67;<i>P</i> = .53) were not associated with achieving these respective outcomes. <h3>Conclusions and Relevance</h3> This study suggests that youths have highly variable PRGs regarding MAT for OUD and that reporting a goal may not mean one is at higher odds of achieving it. There is a need to develop treatment plans that effectively incorporate PRGs. In addition, the finding that most youths aim to minimize or stop their MAT dose warrants the creation of a tapering protocol to guide clinicians. Because a diagnosis of OUD has substantial psychosocial implications in this population, clinicians must ensure that these dimensions of care are part of routine clinical practice." @default.
- W3190198676 created "2021-08-16" @default.
- W3190198676 creator A5000611677 @default.
- W3190198676 creator A5001357223 @default.
- W3190198676 creator A5005839687 @default.
- W3190198676 creator A5027038979 @default.
- W3190198676 creator A5029801001 @default.
- W3190198676 creator A5054958654 @default.
- W3190198676 creator A5057428791 @default.
- W3190198676 creator A5070265721 @default.
- W3190198676 creator A5091903989 @default.
- W3190198676 date "2021-08-05" @default.
- W3190198676 modified "2023-10-11" @default.
- W3190198676 title "Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder" @default.
- W3190198676 cites W1678403806 @default.
- W3190198676 cites W1972113220 @default.
- W3190198676 cites W1992227982 @default.
- W3190198676 cites W2005581629 @default.
- W3190198676 cites W2007847532 @default.
- W3190198676 cites W2020900304 @default.
- W3190198676 cites W2031007413 @default.
- W3190198676 cites W2049229004 @default.
- W3190198676 cites W2049487316 @default.
- W3190198676 cites W2068896196 @default.
- W3190198676 cites W2072107466 @default.
- W3190198676 cites W2094232837 @default.
- W3190198676 cites W2113782694 @default.
- W3190198676 cites W2179881786 @default.
- W3190198676 cites W2213853694 @default.
- W3190198676 cites W2287000876 @default.
- W3190198676 cites W2324645948 @default.
- W3190198676 cites W2586961902 @default.
- W3190198676 cites W2598796960 @default.
- W3190198676 cites W2611486992 @default.
- W3190198676 cites W2741203142 @default.
- W3190198676 cites W2791607419 @default.
- W3190198676 cites W2803056110 @default.
- W3190198676 cites W2906693162 @default.
- W3190198676 cites W2941771041 @default.
- W3190198676 cites W2979651625 @default.
- W3190198676 cites W3001923304 @default.
- W3190198676 cites W3035564334 @default.
- W3190198676 cites W3118360012 @default.
- W3190198676 cites W4232673515 @default.
- W3190198676 cites W4247665917 @default.
- W3190198676 cites W4248877989 @default.
- W3190198676 cites W4294116629 @default.
- W3190198676 doi "https://doi.org/10.1001/jamanetworkopen.2021.19600" @default.
- W3190198676 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8343465" @default.
- W3190198676 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34351402" @default.
- W3190198676 hasPublicationYear "2021" @default.
- W3190198676 type Work @default.
- W3190198676 sameAs 3190198676 @default.
- W3190198676 citedByCount "8" @default.
- W3190198676 countsByYear W31901986762022 @default.
- W3190198676 countsByYear W31901986762023 @default.
- W3190198676 crossrefType "journal-article" @default.
- W3190198676 hasAuthorship W3190198676A5000611677 @default.
- W3190198676 hasAuthorship W3190198676A5001357223 @default.
- W3190198676 hasAuthorship W3190198676A5005839687 @default.
- W3190198676 hasAuthorship W3190198676A5027038979 @default.
- W3190198676 hasAuthorship W3190198676A5029801001 @default.
- W3190198676 hasAuthorship W3190198676A5054958654 @default.
- W3190198676 hasAuthorship W3190198676A5057428791 @default.
- W3190198676 hasAuthorship W3190198676A5070265721 @default.
- W3190198676 hasAuthorship W3190198676A5091903989 @default.
- W3190198676 hasBestOaLocation W31901986761 @default.
- W3190198676 hasConcept C118552586 @default.
- W3190198676 hasConcept C126322002 @default.
- W3190198676 hasConcept C156957248 @default.
- W3190198676 hasConcept C170493617 @default.
- W3190198676 hasConcept C188816634 @default.
- W3190198676 hasConcept C201903717 @default.
- W3190198676 hasConcept C2779418921 @default.
- W3190198676 hasConcept C2780687700 @default.
- W3190198676 hasConcept C2781063702 @default.
- W3190198676 hasConcept C71924100 @default.
- W3190198676 hasConceptScore W3190198676C118552586 @default.
- W3190198676 hasConceptScore W3190198676C126322002 @default.
- W3190198676 hasConceptScore W3190198676C156957248 @default.
- W3190198676 hasConceptScore W3190198676C170493617 @default.
- W3190198676 hasConceptScore W3190198676C188816634 @default.
- W3190198676 hasConceptScore W3190198676C201903717 @default.
- W3190198676 hasConceptScore W3190198676C2779418921 @default.
- W3190198676 hasConceptScore W3190198676C2780687700 @default.
- W3190198676 hasConceptScore W3190198676C2781063702 @default.
- W3190198676 hasConceptScore W3190198676C71924100 @default.
- W3190198676 hasIssue "8" @default.
- W3190198676 hasLocation W31901986761 @default.
- W3190198676 hasLocation W31901986762 @default.
- W3190198676 hasLocation W31901986763 @default.
- W3190198676 hasOpenAccess W3190198676 @default.
- W3190198676 hasPrimaryLocation W31901986761 @default.
- W3190198676 hasRelatedWork W1974829675 @default.
- W3190198676 hasRelatedWork W2034320992 @default.
- W3190198676 hasRelatedWork W2061777679 @default.
- W3190198676 hasRelatedWork W2151958035 @default.
- W3190198676 hasRelatedWork W2514706761 @default.